ATF4 and oculocutaneous albinism: In addition, treatment with ERX-41 induced the activation of downstream targets associated with ERS pathways, such as PERK, p-eIF2α, CHOP, and ATF4, in several OCa models (Figure 3D; Supplementary Figure S2B–D).